NEWS FROM US

Expert Commentary

Use our blog to stay informed, engage with legal experts, and ensure your practice thrives within the complex landscape of healthcare law. Search with keywords such as “HIPAA compliance” or “Anti-Kickback Law” – we cover it all with the expertise and precision you need to help you stay compliant and run your business more efficiently.

The Corporate Practice of Medicine Is No Longer a Passive Compliance Issue

May 14, 2026

By: Carlos Arce, AttorneyHaving represented numerous management service organizations (MSOs) and physician practices throughout the country, I have seen firsthand where these arrangements succeed — and where they become legally

The Regulatory Middle Ground: Navigating Non-Pharmacy Supply Chains in Clinical Practice

May 12, 2026

By: Caitlin A. Kopppenhaver, Attorney The traditional landscape of clinical procurement often centers on two familiar pillars: the 503A compounding pharmacy and the 503B outsourcing facility. Because these entities are

FDA’s Purolea Warning Letter: A Paradigm Shift for AI in Regulated Manufacturing

April 24, 2026

By: Caitlin A. Koppenhaver, Attorney with Florida Healthcare Law Firm and Chief Industry Advisor to APA Purolea Cosmetics Lab – 722591 – 04/02/2026 | FDA When AI Makes Compliance Look Better

Healthcare M&A Trends in 2026: A Shift in Focus Toward Dermatology

April 14, 2026

By: Carlos Arce As we move through the first quarter of 2026, the healthcare acquisition landscape is showing a clear divergence across specialties. While deal activity remains active overall, not

Quality in Healthcare: Beyond the Compounding vs. Manufacturing Debate

March 12, 2026

By: Caitlin A. Koppenhaver, Attorney with Florida Healthcare Law Firm and Chief Industry Advisor to APA There is a persistent tendency in healthcare policy discussions to treat compounding as though it

Why FDA’s New Adverse Event Monitoring System Matters

March 12, 2026

By: Caitlin A. Koppenhaver, Attorney with Florida Healthcare Law Firm and Chief Industry Advisor to APA FDA’s announcement regarding the launch of AEMS is worth watching. The Adverse Event Monitoring System

How to Successfully Launch a Peptide Platform: Balancing Innovation with Regulatory Reality

March 10, 2026

By: Jeff Cohen In the rapidly evolving landscape of modern medicine, peptides have transitioned from the fringes of biohacking into the center of mainstream clinical practice. For Florida medical practices,

From “Scarlet Letter” to a Supply Chain Near You: Some Category 2 Peptides Are Getting a Second Look

March 2, 2026

By: Caitlin A. Koppenhaver A clip from HHS Secretary Robert F. Kennedy Jr.’s recent Joe Rogan Experience appearance has been making the rounds in the peptide and broader wellness industries.

Unlock Your Horizons With a Multistate Nursing License

February 26, 2026

By: Anita Browning, FRP If you are a registered nurse (RN) or licensed practical/vocational nurse (LPN/LVN) and looking to expand your career options, upgrading to a multistate nursing license could

Florida Moves to License Medical Spas: What HB 1429 Means for the Medspa and Wellness Industries

February 13, 2026

By: Caitlin A. Koppenhaver Last Action: 3/13/2026 House – Died in Health Professions & Programs Subcommittee House Bill 1429 (2026) – The Florida Senate Florida’s HB 1429 (and Senate companion SB 1728)

« Prev 1 2 3 4 5 6 7 Next »